From Tissue to Data to Commercial Value: Transformation-Triggered Governance for Human Biospecimens Beyond Informed Consent
Background: Human biospecimens undergo continuous transformation after collection. Tumor fragments may become immortalized cell lines, genomic sequences, research datasets, artificial intelligence inputs, and commercially valuable products. However, research governance often treats informed consent as the primary norma...